ARCHIVES

FDA Describes Meeting With NCI In “Limited” Memo

This article is from The Cancer Letter archive.

Vol. 02 No. 19 | May 7, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

February 17, 1995

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001

MSKCC oncologist settles insider trading case with SEC.

November 11, 2005

UCLA, NYU Get Money, Near comprehensive Identification

May 30, 1975

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014